Cite
HARVARD Citation
Warren, B. et al. (2021). Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single‐center report. Research and practice in thrombosis and haemostasis. 5 (5), p. n/a. [Online].